Literature DB >> 25565926

Novel Deletion of SERPINF1 Causes Autosomal Recessive Osteogenesis Imperfecta Type VI in Two Brazilian Families.

Renata Moldenhauer Minillo1, Nara Sobreira2, Maria de Fatima de Faria Soares1, Julie Jurgens2, Hua Ling3, Kurt N Hetrick3, Kimberly F Doheny3, David Valle2, Decio Brunoni1, Ana B Alvarez Perez1.   

Abstract

Autosomal recessive osteogenesis imperfecta (OI) accounts for 10% of all OI cases, and, currently, mutations in 10 genes (CRTAP, LEPRE1, PPIB, SERPINH1, FKBP10, SERPINF1, SP7, BMP1, TMEM38B, and WNT1) are known to be responsible for this form of the disease. PEDF is a secreted glycoprotein of the serpin superfamily that maintains bone homeostasis and regulates osteoid mineralization, and it is encoded by SERPINF1, currently associated with OI type VI (MIM 172860). Here, we report a consanguineous Brazilian family in which multiple individuals from at least 4 generations are affected with a severe form of OI, and we also report an unrelated individual from the same small city in Brazil with a similar but more severe phenotype. In both families the same homozygous SERPINF1 19-bp deletion was identified which is not known in the literature yet. We described intra- and interfamilial clinical and radiological phenotypic variability of OI type VI caused by the same homozygous SERPINF1 19-bp deletion and suggest a founder effect. Furthermore, the SERPINF1 genotypes/phenotypes reported so far in the literature are reviewed.

Entities:  

Keywords:  Autosomal recessive; Osteogenesis imperfecta type VI; SERPINF1

Year:  2014        PMID: 25565926      PMCID: PMC4281578          DOI: 10.1159/000369108

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  31 in total

1.  Lack of circulating pigment epithelium-derived factor is a marker of osteogenesis imperfecta type VI.

Authors:  Frank Rauch; Abdallah Husseini; Peter Roughley; Francis H Glorieux; Pierre Moffatt
Journal:  J Clin Endocrinol Metab       Date:  2012-06-05       Impact factor: 5.958

2.  WNT1 mutations in early-onset osteoporosis and osteogenesis imperfecta.

Authors:  Christine M Laine; Kyu Sang Joeng; Philippe M Campeau; Riku Kiviranta; Kati Tarkkonen; Monica Grover; James T Lu; Minna Pekkinen; Maija Wessman; Terhi J Heino; Vappu Nieminen-Pihala; Mira Aronen; Tero Laine; Heikki Kröger; William G Cole; Anna-Elina Lehesjoki; Lisette Nevarez; Deborah Krakow; Cynthia J R Curry; Daniel H Cohn; Richard A Gibbs; Brendan H Lee; Outi Mäkitie
Journal:  N Engl J Med       Date:  2013-05-09       Impact factor: 91.245

3.  Lack of expression of SERPINF1, the gene coding for pigment epithelium-derived factor, causes progressively deforming osteogenesis imperfecta with normal type I collagen.

Authors:  Giacomo Venturi; Alberto Gandini; Elena Monti; Luca Dalle Carbonare; Massimiliano Corradi; Monica Vincenzi; Maria Teresa Valenti; Maurizia Valli; Enrico Pelilli; Attilio Boner; Monica Mottes; Franco Antoniazzi
Journal:  J Bone Miner Res       Date:  2012-03       Impact factor: 6.741

4.  Attenuated BMP1 function compromises osteogenesis, leading to bone fragility in humans and zebrafish.

Authors:  P V Asharani; Katharina Keupp; Oliver Semler; Wenshen Wang; Yun Li; Holger Thiele; Gökhan Yigit; Esther Pohl; Jutta Becker; Peter Frommolt; Carmen Sonntag; Janine Altmüller; Katharina Zimmermann; Daniel S Greenspan; Nurten A Akarsu; Christian Netzer; Eckhard Schönau; Radu Wirth; Matthias Hammerschmidt; Peter Nürnberg; Bernd Wollnik; Thomas J Carney
Journal:  Am J Hum Genet       Date:  2012-04-06       Impact factor: 11.025

5.  Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect.

Authors:  Francis H Glorieux; Leanne M Ward; Frank Rauch; Ljiljana Lalic; Peter J Roughley; Rose Travers
Journal:  J Bone Miner Res       Date:  2002-01       Impact factor: 6.741

Review 6.  Osteogenesis imperfecta.

Authors:  Frank Rauch; Francis H Glorieux
Journal:  Lancet       Date:  2004-04-24       Impact factor: 79.321

Review 7.  Recessive osteogenesis imperfecta: clinical, radiological, and molecular findings.

Authors:  Marianne Rohrbach; Cecilia Giunta
Journal:  Am J Med Genet C Semin Med Genet       Date:  2012-07-12       Impact factor: 3.908

8.  EMQN best practice guidelines for the laboratory diagnosis of osteogenesis imperfecta.

Authors:  Fleur S van Dijk; Peter H Byers; Raymond Dalgleish; Fransiska Malfait; Alessandra Maugeri; Marianne Rohrbach; Sofie Symoens; Erik A Sistermans; Gerard Pals
Journal:  Eur J Hum Genet       Date:  2011-08-10       Impact factor: 4.246

9.  Osteogenesis imperfecta Type VI with severe bony deformities caused by novel compound heterozygous mutations in SERPINF1.

Authors:  Sung Yoon Cho; Chang-Seok Ki; Young Bae Sohn; Su Jin Kim; Se Hyun Maeng; Dong-Kyu Jin
Journal:  J Korean Med Sci       Date:  2013-07-03       Impact factor: 2.153

10.  A mutation in the 5'-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus.

Authors:  Oliver Semler; Lutz Garbes; Katharina Keupp; Daniel Swan; Katharina Zimmermann; Jutta Becker; Sandra Iden; Brunhilde Wirth; Peer Eysel; Friederike Koerber; Eckhard Schoenau; Stefan K Bohlander; Bernd Wollnik; Christian Netzer
Journal:  Am J Hum Genet       Date:  2012-08-02       Impact factor: 11.043

View more
  6 in total

1.  New tools for Mendelian disease gene identification: PhenoDB variant analysis module; and GeneMatcher, a web-based tool for linking investigators with an interest in the same gene.

Authors:  Nara Sobreira; François Schiettecatte; Corinne Boehm; David Valle; Ada Hamosh
Journal:  Hum Mutat       Date:  2015-04       Impact factor: 4.878

2.  Genetic analysis of osteogenesis imperfecta in the Palestinian population: molecular screening of 49 affected families.

Authors:  Osama Essawi; Sofie Symoens; Maha Fannana; Mohammad Darwish; Mohammad Farraj; Andy Willaert; Tamer Essawi; Bert Callewaert; Anne De Paepe; Fransiska Malfait; Paul J Coucke
Journal:  Mol Genet Genomic Med       Date:  2017-11-18       Impact factor: 2.183

3.  Pigment epithelium-derived factor restoration increases bone mass and improves bone plasticity in a model of osteogenesis imperfecta type VI via Wnt3a blockade.

Authors:  Glenn S Belinsky; Bharath Sreekumar; Jillian W Andrejecsk; W Mark Saltzman; Jingjing Gong; Raimund I Herzog; Samantha Lin; Valerie Horsley; Thomas O Carpenter; Chuhan Chung
Journal:  FASEB J       Date:  2016-04-28       Impact factor: 5.191

4.  Mutations and altered expression of SERPINF1 in patients with familial otosclerosis.

Authors:  Joanna L Ziff; Michael Crompton; Harry R F Powell; Jeremy A Lavy; Christopher P Aldren; Karen P Steel; Shakeel R Saeed; Sally J Dawson
Journal:  Hum Mol Genet       Date:  2016-04-07       Impact factor: 6.150

5.  Osteogenesis imperfecta in Brazilian patients.

Authors:  Maira Trancozo; Marcos V D Moraes; Dalila A Silva; Jéssica A M Soares; Clara Barbirato; Márcio G Almeida; Lígia R Santos; Maria R G O Rebouças; Akel N Akel; Valentim Sipolatti; Vanda R R Nunes; Flavia I V Errera; Meire Aguena; Maria R Passos-Bueno; Flavia de Paula
Journal:  Genet Mol Biol       Date:  2019-08-15       Impact factor: 1.771

6.  Whole-Exome Sequencing Identifies an Intronic Cryptic Splice Site in SERPINF1 Causing Osteogenesis Imperfecta Type VI.

Authors:  Zixue Jin; Lindsay C Burrage; Ming-Ming Jiang; Yi-Chien Lee; Terry Bertin; Yuqing Chen; Alyssa Tran; Richard A Gibbs; Shalini Jhangiani; V Reid Sutton; Frank Rauch; Brendan Lee; Mahim Jain
Journal:  JBMR Plus       Date:  2018-04-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.